Comparative Effects of Clamshell Technique With EMS vs CTin Iliotibial Band Tightness for Pain and Function
Launched by SUPERIOR UNIVERSITY · May 20, 2024
Trial Information
Current as of November 08, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatment methods for people who have tightness in the iliotibial band (ITB), which can cause pain on the outside of the knee, especially during activities. The goal is to see which method is more effective in reducing pain and improving function for those suffering from this condition. The trial is currently active but not recruiting new participants.
To be eligible for the trial, individuals must be between 45 and 65 years old and have been diagnosed with iliotibial band tightness, confirmed by specific tests. They should also be experiencing lateral knee pain that gets worse with movement. However, people who have had recent knee surgery, other significant knee injuries, or certain medical conditions like arthritis or neurological issues cannot participate. Participants can expect to receive one of the treatment methods being tested, and this research aims to provide better options for managing ITB tightness and related pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 45-65 years old (Jeong et al., 2019)
- • Both genders will be included (Jeong et al., 2019)
- • Diagnosed with iliotibial band tightness (ITBT) based on clinical examination and positive Noble compression test (Hutchinson et al., 2022)
- • Reporting lateral knee pain aggravated by activity (Hutchinson et al., 2022)
- Exclusion Criteria:
- • Recent history of knee surgery or other knee injuries (Peterson et al., 2022)
- • Presence of other musculoskeletal conditions affecting the knee (Peterson et al., 2022)
- • Inflammatory conditions such as rheumatoid arthritis or gout (Peterson et al., 2022)
- • Neurological conditions affecting leg function (Peterson et al., 2022)
- • Pregnancy (Jeong et al., 2019)
About Superior University
Superior University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the university fosters a collaborative environment that brings together multidisciplinary teams of researchers, clinicians, and students. Superior University is focused on exploring novel therapeutic approaches and improving patient outcomes, leveraging its state-of-the-art facilities and cutting-edge technology. The institution adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and impact of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported